CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | Bonstein Sara Chief Financial Officer | Grant or award | +5,065 | 68,888 | ||
| 2023-01-05 | Bonstein Sara Chief Financial Officer | Grant or award · Stock Option (right to buy) | +37,760 | 37,760 | ||
| 2023-01-05 | Lewis William Chair and CEO | Sale | −7,008 | $19.80 | $139K | 249,708 |
| 2023-01-05 | Lewis William Chair and CEO | Grant or award | +22,353 | 272,061 | ||
| 2023-01-05 | Lewis William Chair and CEO | Grant or award · Stock Option (right to buy) | +102,540 | 102,540 | ||
| 2023-01-05 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −1,448 | $19.73 | $29K | 68,262 |
| 2023-01-05 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award | +6,332 | 74,594 | ||
| 2023-01-05 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award · Stock Option (right to buy) | +29,050 | 29,050 | ||
| 2022-11-22 | Wise John Drayton Chief Commercial Officer | Sale | −7,154 | $18.84 | $135K | 71,613 |
| 2022-11-22 | Adsett Roger Chief Operating Officer | Sale | −11,855 | $18.80 | $223K | 134,127 |
| 2022-11-01 | SHAROKY MELVIN MD Director | Purchase | +10,000 | $17.70 | $177K | 15,900 |
| 2022-10-31 | LEE LEO Director | Purchase | +45,000 | $17.69 | $796K | 98,265 |
| 2022-10-31 | SHAROKY MELVIN MD Director | Purchase | +20,000 | $17.53 | $351K | 281,021 |
| 2022-08-10 | Wise John Drayton Chief Commercial Officer | Sale | −258 | $27.79 | $7K | 78,767 |
| 2022-08-08 | Lewis William Chair and CEO | Exercise or conversion | +24,430 | $3.40 | $83K | 24,430 |
| 2022-08-08 | Lewis William Chair and CEO | Sale | −24,430 | $27.67 | $676K | 0 |
| 2022-08-08 | Lewis William Chair and CEO | Exercise or conversion | +6,200 | $3.40 | $21K | 6,200 |
| 2022-08-08 | Lewis William Chair and CEO | Sale | −6,200 | $28.45 | $176K | 0 |
| 2022-08-08 | Lewis William Chair and CEO | Exercise or conversion | +161,193 | $4.55 | $733K | 161,193 |
| 2022-08-08 | Lewis William Chair and CEO | Sale | −161,193 | $27.75 | $4.5M | 0 |
Page 50 of 54 · 1,061 trades